Eugene Williams bought $92k of PMN
director at ProMIS Neurosciences Inc.. 4,000 shares at an average of $23.11, traded Mar 2, 2026, filed Mar 4, 2026.
Score components
- +15RoleDirector
- +9Trade size$92k at market
- +10Relative to holdingsHoldings up 63%
- +4Price context19% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -48.0%, 3m -59.9%, 6m -41.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001374339-26-000003, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | POpen-market purchase Common Shares | +1,000 | $22.53 | $23k | 7,397 | Mar 4, 2026 |
| Mar 3, 2026 | POpen-market purchase Common Shares | +1,000 | $21.89 | $22k | 8,397 | Mar 4, 2026 |
| Mar 4, 2026 | POpen-market purchase Common Shares | +2,000 | $24.00 | $48k | 10,397 | Mar 4, 2026 |
Related signals
Other insiders at ProMIS Neurosciences Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | PMNbuy ProMIS Neurosciences Inc. | Johanne Kaplan Chief Development Officer | $30k 2,280 shares | +58% | |
| 39Weak | PMNbuy ProMIS Neurosciences Inc. | Patrick D. Kirwin director | $45k 4,000 shares | +613% | |
| 38Weak | ProMIS Neurosciences Inc. | Eugene Williams director | $49k 2,000 shares | +19% | |
| 46Moderate | ProMIS Neurosciences Inc. | Johanne Kaplan Chief Development Officer | $25k 1,629 shares | +70% | |
| 58Moderate | PMNbuy ProMIS Neurosciences Inc. | Slanix Paul Alex director | $8.5M 700,741 shares | +289% | |
| 26Weak | PMNbuy ProMIS Neurosciences Inc. | Max A. Milbury Principal Accounting Officer | $15k 30,392 shares | +203% | |
| 25Weak | PMNbuy ProMIS Neurosciences Inc. | Neil Cashman Chief Scientific Officer | $15k 15,000 shares | +928% | |
| 54Moderate | ProMIS Neurosciences Inc. | Madge K. Shafmaster director | $256k 200,000 shares | +2400% | |
| 41Moderate | ProMIS Neurosciences Inc. | Michael S Gordon owner | $117k 93,223 shares | - | |
| 26Weak | PMNbuy ProMIS Neurosciences Inc. | Patrick D. Kirwin director | $12k 10,000 shares | +19% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.